These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32261669)

  • 1. A novel strategy to fabricate doxorubicin/bovine serum albumin/porous silicon nanocomposites with pH-triggered drug delivery for cancer therapy in vitro.
    Xia B; Zhang W; Shi J; Xiao SJ
    J Mater Chem B; 2014 Aug; 2(32):5280-5286. PubMed ID: 32261669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
    Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
    Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy.
    Xue Y; Bai H; Peng B; Tieu T; Jiang J; Hao S; Li P; Richardson M; Baell J; Thissen H; Cifuentes A; Li L; Voelcker NH
    Adv Healthc Mater; 2022 Jun; 11(12):e2200076. PubMed ID: 35306736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photothermal and biodegradable polyaniline/porous silicon hybrid nanocomposites as drug carriers for combined chemo-photothermal therapy of cancer.
    Xia B; Wang B; Shi J; Zhang Y; Zhang Q; Chen Z; Li J
    Acta Biomater; 2017 Mar; 51():197-208. PubMed ID: 28069501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered stealth porous silicon nanoparticles via surface encapsulation of bovine serum albumin for prolonging blood circulation in vivo.
    Xia B; Zhang W; Shi J; Xiao SJ
    ACS Appl Mater Interfaces; 2013 Nov; 5(22):11718-24. PubMed ID: 24138109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional Chitosan/Porous Silicon@Au Nanocomposite Hydrogels for Long-Term and Repeatedly Localized Combinatorial Therapy of Cancer via a Single Injection.
    Xia B; Zhang W; Tong H; Li J; Chen Z; Shi J
    ACS Biomater Sci Eng; 2019 Apr; 5(4):1857-1867. PubMed ID: 33405559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. pH-sensitive Au-BSA-DOX-FA nanocomposites for combined CT imaging and targeted drug delivery.
    Huang H; Yang DP; Liu M; Wang X; Zhang Z; Zhou G; Liu W; Cao Y; Zhang WJ; Wang X
    Int J Nanomedicine; 2017; 12():2829-2843. PubMed ID: 28435261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
    Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
    ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and characterization of mesoporous magnetic nanocomposites wrapped with chitosan gatekeepers for pH-sensitive controlled release of doxorubicin.
    Wu J; Jiang W; Shen Y; Jiang W; Tian R
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):132-140. PubMed ID: 27770872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photoluminescent and biodegradable porous silicon nanoparticles for biomedical imaging.
    Park Y; Yoo J; Kang MH; Kwon W; Joo J
    J Mater Chem B; 2019 Nov; 7(41):6271-6292. PubMed ID: 31393507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domino-Like Intercellular Delivery of Undecylenic Acid-Conjugated Porous Silicon Nanoparticles for Deep Tumor Penetration.
    Yong T; Hu J; Zhang X; Li F; Yang H; Gan L; Yang X
    ACS Appl Mater Interfaces; 2016 Oct; 8(41):27611-27621. PubMed ID: 27653799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-Incorporated Nanotherapeutic Delivery System Based on Gelatin-Coated Gold Nanoparticles: Formulation, Drug Release, and Multimodal Imaging of Cellular Internalization.
    Suarasan S; Focsan M; Potara M; Soritau O; Florea A; Maniu D; Astilean S
    ACS Appl Mater Interfaces; 2016 Sep; 8(35):22900-13. PubMed ID: 27537061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Natural gelatin capped mesoporous silica nanoparticles for intracellular acid-triggered drug delivery.
    Zou Z; He D; He X; Wang K; Yang X; Qing Z; Zhou Q
    Langmuir; 2013 Oct; 29(41):12804-10. PubMed ID: 24073830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BSA-based Cu
    Liu Z; Chan L; Ye X; Bai Y; Chen T
    Colloids Surf B Biointerfaces; 2018 Dec; 172():298-307. PubMed ID: 30173097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sericin nanomicelles with enhanced cellular uptake and pH-triggered release of doxorubicin reverse cancer drug resistance.
    Guo W; Deng L; Yu J; Chen Z; Woo Y; Liu H; Li T; Lin T; Chen H; Zhao M; Zhang L; Li G; Hu Y
    Drug Deliv; 2018 Nov; 25(1):1103-1116. PubMed ID: 29742945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combinatory Cancer Therapeutics with Nanoceria-Capped Mesoporous Silica Nanocarriers through pH-triggered Drug Release and Redox Activity.
    Singh RK; Patel KD; Mahapatra C; Parthiban SP; Kim TH; Kim HW
    ACS Appl Mater Interfaces; 2019 Jan; 11(1):288-299. PubMed ID: 30539634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Black TiO
    Ren W; Iqbal MZ; Zeng L; Chen T; Pan Y; Zhao J; Yin H; Zhang L; Zhang J; Li A; Wu A
    Nanoscale; 2017 Aug; 9(31):11195-11204. PubMed ID: 28749498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pH-responsive alginate/chitosan multilayers coating on delivery efficiency, cellular uptake and biodistribution of mesoporous silica nanoparticles based nanocarriers.
    Feng W; Nie W; He C; Zhou X; Chen L; Qiu K; Wang W; Yin Z
    ACS Appl Mater Interfaces; 2014 Jun; 6(11):8447-60. PubMed ID: 24745551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protein@metal-organic framework nanocomposite for pH-triggered anticancer drug delivery.
    Liang Z; Yang Z; Yuan H; Wang C; Qi J; Liu K; Cao R; Zheng H
    Dalton Trans; 2018 Jul; 47(30):10223-10228. PubMed ID: 30014058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.